• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Y 盒结合蛋白 1/细胞周期蛋白 A1 轴特异性促进卵巢癌细胞在 G/M 期的细胞周期进程。

Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G/M phase in ovarian cancer.

机构信息

Basic Medical Research Unit, St. Mary's Research Center, 422 Tsubukuhon-Machi, Kurume, Fukuoka, 830-8543, Japan.

Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.

出版信息

Sci Rep. 2024 Sep 17;14(1):21701. doi: 10.1038/s41598-024-72174-9.

DOI:10.1038/s41598-024-72174-9
PMID:39289424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11408696/
Abstract

Y-box binding protein 1 (YBX1) promotes oncogenic transformation and tumor growth. YBX1 plays a role in regulation of cell cycle promotion via upregulation of cell cycle-related genes. In ovarian cancer, YBX1 also promotes tumor growth, but the mechanisms of YBX1 in cell growth and cell cycle in ovarian cancer remain not to be fully understood. Here, we investigated whether YBX1-dependent cancer cell proliferation was specifically associated with expression of cell cycle related genes in ovarian cancer. Protein and mRNA expression levels of YBX1 and cell cycle-related genes in ovarian cancer cell lines and tissues were determined by western blot analysis, immunohistochemical analysis and reverse transcription-quantitative PCR. Cell cycle analysis was performed by flow cytometry. Luciferase assay and Chromatin immunoprecipitation assay were used to investigate a transcriptional function of YBX1. YBX1 silencing induced marked growth suppression in 4 cell lines (group A), moderate suppression in 5 cell lines (group B), and no suppression in 3 cell lines (group C) among 12 ovarian cancer cell lines in culture. The YBX1 silencing induced cell cycle arrest at G/M phase and suppressed expression of cyclin A1 gene in group A and B cell lines, but not in group C cell lines. Cyclin A1 silencing specifically suppressed cell proliferation in group A cell lines and partially in group B cell lines, but not at all in group C cell lines. YBX1 mRNA levels were significantly correlated with cyclin A1 mRNA levels in patients with high-grade serous carcinoma. Augmented YBX1 expression plays a key role in tumor growth promotion in ovarian cancer in its close association with cyclin A1.

摘要

Y 盒结合蛋白 1(YBX1)促进致癌转化和肿瘤生长。YBX1 通过上调细胞周期相关基因在细胞周期促进中起作用。在卵巢癌中,YBX1 也促进肿瘤生长,但 YBX1 在卵巢癌细胞生长和细胞周期中的作用机制尚未完全阐明。在这里,我们研究了 YBX1 依赖性癌细胞增殖是否与卵巢癌细胞中细胞周期相关基因的表达特异性相关。通过 Western blot 分析、免疫组织化学分析和逆转录定量 PCR 测定卵巢癌细胞系和组织中的 YBX1 和细胞周期相关基因的蛋白和 mRNA 表达水平。通过流式细胞术进行细胞周期分析。使用荧光素酶测定和染色质免疫沉淀测定来研究 YBX1 的转录功能。在培养的 12 种卵巢癌细胞系中,YBX1 沉默在 4 种细胞系(A 组)中引起明显的生长抑制,在 5 种细胞系(B 组)中引起中度抑制,在 3 种细胞系(C 组)中没有抑制。YBX1 沉默在 A 组和 B 组细胞系中诱导细胞周期停滞在 G2/M 期,并抑制细胞周期蛋白 A1 基因的表达,但在 C 组细胞系中没有抑制。细胞周期蛋白 A1 沉默特异性抑制 A 组细胞系和部分 B 组细胞系的细胞增殖,但对 C 组细胞系完全没有抑制。在高级别浆液性癌患者中,YBX1 mRNA 水平与 cyclin A1 mRNA 水平显著相关。增强的 YBX1 表达与其与 cyclin A1 的密切关联在卵巢癌的肿瘤生长促进中起着关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911f/11408696/e06a4b540faa/41598_2024_72174_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911f/11408696/26883a8ef3d8/41598_2024_72174_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911f/11408696/efc460fc3cd6/41598_2024_72174_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911f/11408696/78e81edd8001/41598_2024_72174_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911f/11408696/56fdba52881d/41598_2024_72174_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911f/11408696/e06a4b540faa/41598_2024_72174_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911f/11408696/26883a8ef3d8/41598_2024_72174_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911f/11408696/efc460fc3cd6/41598_2024_72174_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911f/11408696/78e81edd8001/41598_2024_72174_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911f/11408696/56fdba52881d/41598_2024_72174_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/911f/11408696/e06a4b540faa/41598_2024_72174_Fig5_HTML.jpg

相似文献

1
Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G/M phase in ovarian cancer.Y 盒结合蛋白 1/细胞周期蛋白 A1 轴特异性促进卵巢癌细胞在 G/M 期的细胞周期进程。
Sci Rep. 2024 Sep 17;14(1):21701. doi: 10.1038/s41598-024-72174-9.
2
YBX1 regulated by Runx3-miR-148a-3p axis facilitates non-small-cell lung cancer progression.由Runx3-miR-148a-3p轴调控的YBX1促进非小细胞肺癌进展。
Cell Signal. 2021 Sep;85:110049. doi: 10.1016/j.cellsig.2021.110049. Epub 2021 May 31.
3
CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1.CTPS1 通过 YBX1 的转录激活促进三阴性乳腺癌的恶性进展。
J Transl Med. 2022 Jan 6;20(1):17. doi: 10.1186/s12967-021-03206-5.
4
The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1.去泛素化酶 USP5 通过稳定 YBX1 促进胆管癌进展。
Life Sci. 2024 Jul 1;348:122674. doi: 10.1016/j.lfs.2024.122674. Epub 2024 Apr 29.
5
Regulatory mechanism of interaction between Y-box-binding protein 1 and heterogenous nuclear ribonucleoprotein K in cell division cycle 25a signal pathway and lung cancer metastasis.Y 盒结合蛋白 1 与异质核核糖核蛋白 K 在细胞分裂周期 25a 信号通路中的相互作用调控机制及其与肺癌转移的关系。
Cell Mol Biol (Noisy-le-grand). 2023 Dec 20;69(14):62-68. doi: 10.14715/cmb/2023.69.14.10.
6
RNA mC modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer.mC 修饰的 RNA 通过依赖于 YBX1 相分离的方式上调 E2F1 的表达,并促进卵巢癌的肿瘤进展。
Exp Mol Med. 2024 Mar;56(3):600-615. doi: 10.1038/s12276-024-01184-4. Epub 2024 Mar 1.
7
LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1.长链非编码 RNA HOXC-AS3 通过上调 YBX1 促进非小细胞肺癌的生长和转移。
Cell Death Dis. 2022 Apr 6;13(4):307. doi: 10.1038/s41419-022-04723-x.
8
Foxo3a drives proliferation in anaplastic thyroid carcinoma through transcriptional regulation of cyclin A1: a paradigm shift that impacts current therapeutic strategies.Foxo3a 通过转录调控细胞周期蛋白 A1 驱动间变性甲状腺癌的增殖:这一范式转变影响了当前的治疗策略。
J Cell Sci. 2012 Sep 15;125(Pt 18):4253-63. doi: 10.1242/jcs.097428. Epub 2012 Jun 20.
9
YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.YBX1通过细胞周期蛋白依赖性激酶25A(CDC25a)途径调控人肺腺癌中的肿瘤生长。
Oncotarget. 2016 Dec 13;7(50):82139-82157. doi: 10.18632/oncotarget.10080.
10
Circ_0002762 Regulates Oncoprotein YBX1 in Cervical Cancer via mir-375 to Regulate the Malignancy of Cancer Cells.环状 RNA 0002762 通过 miR-375 调控宫颈癌致癌蛋白 YBX1 以调控癌细胞恶性。
Protein Pept Lett. 2023;30(2):162-172. doi: 10.2174/0929866530666230104155209.

本文引用的文献

1
PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in Gastric Cancer.PICH 通过激活细胞周期蛋白 A1 转录来驱动胃癌中的 S 期进程和化疗耐药性。
Cancer Res. 2023 Nov 15;83(22):3767-3782. doi: 10.1158/0008-5472.CAN-23-1331.
2
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.CCNE1 与输卵管-卵巢高级别浆液性癌患者的生存:卵巢肿瘤组织分析联盟研究。
Cancer. 2023 Mar 1;129(5):697-713. doi: 10.1002/cncr.34582. Epub 2022 Dec 26.
3
Targeting Therapeutic Resistance and Multinucleate Giant Cells in CCNE1-Amplified HR-Proficient Ovarian Cancer.
靶向 CCNE1 扩增的 HR proficient 卵巢癌中的治疗抵抗和多核巨细胞
Mol Cancer Ther. 2022 Sep 6;21(9):1473-1484. doi: 10.1158/1535-7163.MCT-21-0873.
4
Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives.抑制CDK4/6作为卵巢癌患者的治疗方法:当前证据与未来展望
Cancers (Basel). 2021 Jun 17;13(12):3035. doi: 10.3390/cancers13123035.
5
RNA-binding protein YBX1 promotes cell proliferation and invasiveness of nasopharyngeal carcinoma cells binding to AURKA mRNA.RNA 结合蛋白 YBX1 通过与 AURKA mRNA 结合促进鼻咽癌细胞的增殖和侵袭。
J Cancer. 2021 Apr 7;12(11):3315-3324. doi: 10.7150/jca.56262. eCollection 2021.
6
Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer.Y 盒结合蛋白 1 抑制作为卵巢癌的一种靶向治疗。
Cell Chem Biol. 2021 Aug 19;28(8):1206-1220.e6. doi: 10.1016/j.chembiol.2021.02.014. Epub 2021 Mar 12.
7
YB-1 Knockdown Inhibits the Proliferation of Mesothelioma Cells through Multiple Mechanisms.YB-1基因敲低通过多种机制抑制间皮瘤细胞的增殖。
Cancers (Basel). 2020 Aug 14;12(8):2285. doi: 10.3390/cancers12082285.
8
Dephosphorylation of YB-1 is Required for Nuclear Localisation During G Phase of the Cell Cycle.细胞周期G期核定位需要YB-1去磷酸化。
Cancers (Basel). 2020 Jan 29;12(2):315. doi: 10.3390/cancers12020315.
9
Targeting Phosphorylation of Y-Box-Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen Resistance.TAS0612 和依维莫司通过靶向 Y 盒结合蛋白 YBX1 的磷酸化克服抗雌激素耐药。
Mol Cancer Ther. 2020 Mar;19(3):882-894. doi: 10.1158/1535-7163.MCT-19-0690. Epub 2019 Dec 26.
10
Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer.致癌性 Y 框结合蛋白 1 作为耐药性癌症的有效治疗靶点。
Cancer Sci. 2019 May;110(5):1536-1543. doi: 10.1111/cas.14006. Epub 2019 Apr 7.